Dow Up 0.76% Nasdaq Up 0.69%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
93.84 Up 2.03(2.21%) Oct 24, 4:00PM EDT
Prev Close:91.81
Open:90.90
Bid:88.00 x 600
Ask:94.00 x 100
1y Target Est:106.33
Beta:2.11
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:90.90 - 94.99
52wk Range:47.03 - 112.57
Volume:739,201
Avg Vol (3m):700,432
Market Cap:7.17B
P/E (ttm):N/A
EPS (ttm):-5.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALNY

Comparison

Symbol% ChgMkt Cap
ALNYUp 2.21%7.17B
MRKUp 1.73%166.18B
PFEUp 1.78%184.58B
VRXUp 0.87%43.31B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):197.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-5.40
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and commercializing novel therapeutics based on RNA interference (RNAi). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback